Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2OTHER_GOV 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Dermatologic 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Nevi and Melanomas 1Neoplasms, Unknown Primary 1Neoplasms 1Melanoma 1Genetic Predisposition to Disease 1Disease 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Sequence Analysis, RNA × Clear all
NCT07366008 2026-01-26

NorCUP

Haukeland University Hospital

Phase NA Not yet recruiting
350 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT04620278 2026-01-06

Genetic Investigation of Cancer Predisposition

The University of Texas Health Science Center at San Antonio

Not yet recruiting
100 enrolled

Disease, Neoplasms, Genetic Predisposition to Disease

NCT06605417 2025-02-27

NevustoMel

Fundacion Clinic per a la Recerca Biomédica

Recruiting
100 enrolled
Dermatologic

Melanoma, Nevi and Melanomas

NCT04745975 2022-04-20

Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer

Fudan University

Phase 2 Unknown
100 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡